Filing Details
- Accession Number:
- 0001288123-10-000065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-14 14:38:18
- Reporting Period:
- 2010-09-10
- Filing Date:
- 2010-09-14
- Accepted Time:
- 2010-09-14 14:38:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1098972 | Antigenics Inc | AGEN | Biological Products, (No Disgnostic Substances) (2836) | 061562417 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1369453 | Kerry Wentworth | C/O Antigenics Inc. 162 Fifth Ave., Suite 900 New York NY 10010 | Vp, Clin, Reg & Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-09-10 | 5,000 | $0.93 | 145,541 | No | 4 | A | Direct | |
Common Stock | Disposition | 2010-09-14 | 1,453 | $0.91 | 144,088 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents settlement of restricted stock awarded September 10, 2008.
- Represents shares sold to cover minimum federal, state, and local tax withholding requirements upon the vesting of the restricted shares awarded on September 10, 2008.